Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of May 14, 2025 • 2:01 PM ET

Date/Time Source News Release
05/12/2025 04:28 PM EDT GlobeNewswire Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones
05/07/2025 08:30 AM EDT GlobeNewswire Orchestra BioMed's AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart Failure
04/29/2025 09:00 AM EDT GlobeNewswire Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon
04/28/2025 04:30 PM EDT GlobeNewswire Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
04/23/2025 09:00 AM EDT GlobeNewswire Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting
04/22/2025 07:00 AM EDT GlobeNewswire Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy
03/31/2025 04:21 PM EDT GlobeNewswire Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update
02/20/2025 08:00 AM EST GlobeNewswire Orchestra BioMed to Present at Upcoming Investor Conferences
02/18/2025 08:00 AM EST GlobeNewswire Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board
02/12/2025 10:43 AM EST GlobeNewswire Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference
Page
  • 1
  • 2

Additional News

As of May 14, 2025 • 2:01 PM ET

Date/Time Source News Release
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.